Are the Pure In Situ Breast Ductal Carcinomas and Those Associated With Invasive Carcinoma the Same?-Reference-Cited by-同舟云学术

Are the Pure In Situ Breast Ductal Carcinomas and Those Associated With Invasive Carcinoma the Same?

Published:2010-01 Issue:1 Volume:18 Page:51-54
ISSN:1541-2016
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:

Author:

Schorr Mario Casales,Pedrini José Luiz,Savaris Ricardo Francalacci,Zettler Cláudio Galleano

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Histology,Pathology and Forensic Medicine

Reference19 articles.

1. Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution;Allred;Clin Cancer Res,2008

2. Ductal carcinoma in situ: a review of recent advances;Tang;Curr Opin Obstet Gynecol,2007

3. Pure ductal carcinoma in situ and in situ component of ductal invasive carcinoma of the breast. A preliminary morphometric study;Giardina;J Exp Clin Cancer Res,2003

4. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast;Steinman;Ann Clin Lab Sci,2007

5. Reassessing tumor markers in local recurrences of breast cancer: a new insight;Pedrini;Med Sci Monit,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological features of breast cancer progression: From DCIS to invasive ductal carcinoma;2023-10-10

2. Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches;Journal of Controlled Release;2022-09

3. Does concomitant ductal carcinoma in situ affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: An Asian perspective;Cancer Reports;2022-07-26

4. Does Existence of Ductal Carcinoma In Situ Accompanying Invasive Ductal Carcinoma Lead to Different Clinicopathological Features and Clinical Outcome? Report of a Breast Cancer Registry;MIDDLE EAST J CANCER;2022

5. Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsy;Scientific Reports;2022-02-09